BOSULIF 500mg film-coated tablets PFIZER
bosutinib Indicated for: chronic myeloid leukemia
letter B · page 29
bosutinib Indicated for: chronic myeloid leukemia
bosutinib Indicated for: chronic myeloid leukemia
bosutinib Indicated for: chronic myeloid leukemia
bosutinib Indicated for: chronic myeloid leukemia
botulinum toxin type A Indicated for: spasticity; dystonias; neuromuscular disorders
botulinum toxin type A Indicated for: spasticity; dystonias; neuromuscular disorders
botulinum toxin type A Indicated for: spasticity; dystonias; neuromuscular disorders
botulinum antitoxin Indicated for: botulism
botulinum antitoxin Indicated for: botulism
teriflunomide Indicated for: multiple sclerosis
teriflunomide Indicated for: multiple sclerosis
glatiramer acetate Indicated for: multiple sclerosis
encorafenib Indicated for: melanoma; colorectal cancer
encorafenib Indicated for: melanoma; colorectal cancer
Tc 99m - exametazime Indicated for: diagnostic imaging
V09AA01 Various | Central nervous system | Technetium (99mtc) compounds
temozolomide Indicated for: malignant glioma
L01AX03 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
temozolomide Indicated for: malignant glioma
L01AX03 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
temozolomide Indicated for: malignant glioma
L01AX03 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
temozolomide Indicated for: malignant glioma
L01AX03 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents
temozolomide Indicated for: malignant glioma
L01AX03 Antineoplastic and immunomodulating agents | Alkylating agents | Other alkylating agents